QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Komoroski, B. J. Articles by Venkataramanan, R. Search for Related Content PubMed PubMed Citation Articles by Komoroski, B. J. Articles by Venkataramanan, R.

INDUCTION AND INHIBITION OF CYTOCHROMES P450 BY THE ST. JOHN'S WORT CONSTITUENT HYPERFORIN IN HUMAN HEPATOCYTE CULTURES

Department of Pharmaceutical Sciences, School of Pharmacy, University of Pittsburgh (B.J.K., S.Z., R.F., R.V.), and Department of Pathology, School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania (H.C., S.C.S., T.L., R.V.); West Virginia University, School of Pharmacy, Morgantown, West Virginia (M.H., T.S.T.); and Division of Chemistry, National Center for Toxicological Research, Food and Drug Administration, Jefferson, Arkansas (C.Y.W.A., Y.Y.C.)

St. John's wort extract (SJW) (Hypericum perforatum L.) is among the most commonly used herbal medications in the United States. The predominance of clinical reports indicates that SJW increases the activity of cytochrome P450 3A4 (CYP3A4) enzyme and reduces plasma concentrations of certain drugs. Although the inductive effect of SJW on CYP3A4 is clear, other reports indicate that SJW constituents may have, to a small degree, some enzyme inhibitory effects. Therefore, we sought to study the induction and inhibition effects of the constituents of SJW on CYP3A4 in the human hepatocyte model. Moreover, most research has focused on the induction of CYP3A4 by SJW with little attention paid to other prominent drug-metabolizing enzymes such as CYP1A2, CYP2C9, and CYP2D6. To examine the effects of SJW on CYP1A2, CYP2C9, CYP2D6, as well as CYP3A4, hepatocytes were exposed to hyperforin and hypericin, the primary constituents of SJW extract. Hepatocytes treated with hypericin or hyperforin were exposed to probe substrates to determine enzyme activity and protein and RNA harvested. Hyperforin treatment resulted in significant increases in mRNA, protein, and activity of CYP3A4 and CYP2C9, but had no effect on CYP1A2 or CYP2D6. Acute administration of hyperforin at 5 and 10 µM 1 h before and along with probe substrate inhibited CYP3A4 activity. Hypericin had no effect on any of the enzymes tested. These results demonstrate that with chronic exposure, the inductive effect of SJW on drug-metabolizing enzymes predominates, and human hepatocyte cultures are a versatile in vitro tool for screening the effect of herbal products on cytochrome P450 enzymes.

This article has been cited by other articles:

				S. S. Shord, K. Shah, and A. Lukose Drug--Botanical Interactions: A Review of the Laboratory, Animal, and Human Data for 8 Common Botanicals Integr Cancer Ther, September 1, 2009; 8(3): 208 - 227. [Abstract] [PDF]

				Y. Chen, S. Coulter, A. M. Jetten, and J. A. Goldstein Identification of Human CYP2C8 as a Retinoid-Related Orphan Nuclear Receptor Target Gene J. Pharmacol. Exp. Ther., April 1, 2009; 329(1): 192 - 201. [Abstract] [Full Text] [PDF]

				S. Surapureddi, R. Rana, J. K. Reddy, and J. A. Goldstein Nuclear Receptor Coactivator 6 Mediates the Synergistic Activation of Human Cytochrome P-450 2C9 by the Constitutive Androstane Receptor and Hepatic Nuclear Factor-4{alpha} Mol. Pharmacol., September 1, 2008; 74(3): 913 - 923. [Abstract] [Full Text] [PDF]

				P. Stock, D. Monga, X. Tan, A. Micsenyi, N. Loizos, and S. P.S. Monga Platelet-derived growth factor receptor-{alpha}: a novel therapeutic target in human hepatocellular cancer Mol. Cancer Ther., July 1, 2007; 6(7): 1932 - 1941. [Abstract] [Full Text] [PDF]

				R. S. Foti, J. L. Wahlstrom, and L. C. Wienkers The in Vitro Drug Interaction Potential of Dietary Supplements Containing Multiple Herbal Components Drug Metab. Dispos., February 1, 2007; 35(2): 185 - 188. [Abstract] [Full Text] [PDF]

				S. Mirkov, B. J. Komoroski, J. Ramirez, A. Y. Graber, M. J. Ratain, S. C. Strom, and F. Innocenti Effects of Green Tea Compounds on Irinotecan Metabolism Drug Metab. Dispos., February 1, 2007; 35(2): 228 - 233. [Abstract] [Full Text] [PDF]

				Q. Du, K. S. Park, Z. Guo, P. He, M. Nagashima, L. Shao, R. Sahai, D. A. Geller, and S. P. Hussain Regulation of Human Nitric Oxide Synthase 2 Expression by Wnt {beta}-Catenin Signaling. Cancer Res., July 15, 2006; 66(14): 7024 - 7031. [Abstract] [Full Text] [PDF]

				Y. Mu, J. Zhang, S. Zhang, H.-H. Zhou, D. Toma, S. Ren, L. Huang, M. Yaramus, A. Baum, R. Venkataramanan, et al. Traditional Chinese Medicines Wu Wei Zi (Schisandra chinensis Baill) and Gan Cao (Glycyrrhiza uralensis Fisch) Activate Pregnane X Receptor and Increase Warfarin Clearance in Rats J. Pharmacol. Exp. Ther., March 1, 2006; 316(3): 1369 - 1377. [Abstract] [Full Text] [PDF]

				B. J. Komoroski, R. A. Parise, M. J. Egorin, S. C. Strom, and R. Venkataramanan Effect of the St. John's Wort Constituent Hyperforin on Docetaxel Metabolism by Human Hepatocyte Cultures Clin. Cancer Res., October 1, 2005; 11(19): 6972 - 6979. [Abstract] [Full Text] [PDF]

				Y. Chen, G. Kissling, M. Negishi, and J. A. Goldstein The Nuclear Receptors Constitutive Androstane Receptor and Pregnane X Receptor Cross-Talk with Hepatic Nuclear Factor 4{alpha} to Synergistically Activate the Human CYP2C9 Promoter J. Pharmacol. Exp. Ther., September 1, 2005; 314(3): 1125 - 1133. [Abstract] [Full Text] [PDF]